Will Dick's (DKS) Beat Estimates Again in Its Next Earnings Report? — Positive

DKS   Zacks Investment Research — May 16, 2025

Dick's (DKS) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

image for news Will Dick's (DKS) Beat Estimates Again in Its Next Earnings Report?

SECAUCUS, N.J. , May 16, 2025 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), a leader in diagnostic information services, announced that Jim Davis, Chairman, CEO and President, will speak on the company's strategy, performance and the latest market developments and trends during a presentation at the William Blair 45th Annual Growth Stock Conference in Chicago on Tuesday, June 3, 2025, at 11:00 a.m.

image for news Quest Diagnostics to Speak at the William Blair 45th Annual Growth Stock Conference

NEW YORK, May 16, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Actinium Pharmaceuticals, Inc. ("Actinium" or the "Company") (NYSE: ATNM) of a class action securities lawsuit.

image for news Investors who lost money on Actinium Pharmaceuticals, Inc.(ATNM) should contact Levi & Korsinsky about pending Class Action - ATNM

Burry's firm now owns 200,000 shares of Estee valued at $13.2 million.

image for news ‘Big Short' investor Michael Burry doubles stake in Estee Lauder, betting on luxe rebound

NEW YORK, May 16, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Rocket Companies, Inc. ("Rocket Companies" or the "Company") (NYSE: RKT) of a class action securities lawsuit.

image for news Investors in Rocket Companies, Inc. Should Contact Levi & Korsinsky Before July 8, 2025 to Discuss Your Rights – RKT

LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, announces that a securities fraud class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Elevance Health, Inc. (“Elevance” or the “Company”) (NYSE: ELV) common stock between April 18, 2024, and October 16, 2024, inclusive (the “Class Period”). Elevance investors have until July 11, 2025 to file a lead plaintiff motion. IF YOU SUFFERED A LOSS ON Y.

image for news Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Encourages Elevance Health, Inc. (ELV) Investors To Inquire About Securities Fraud Class Action

Veralto's Growth Prospects Shine Despite Competitive Risks — Positive

VLTO   Zacks Investment Research — May 16, 2025

VLTO's leadership in Water Quality and PQI segments, strategic acquisitions and growing dividends position it for sustained growth.

image for news Veralto's Growth Prospects Shine Despite Competitive Risks

FTNT vs. CSCO: Which Network Security Giant is the Better Investment? — Neutral

CSCO  FTNT   Zacks Investment Research — May 16, 2025

Fortinet FTNT and Cisco Sytems CSCO are well-established players in the network security market. Both offer enterprise-grade cybersecurity solutions and network infrastructure, with Fortinet focused purely on security and Cisco blending security with broader networking products.

image for news FTNT vs. CSCO: Which Network Security Giant is the Better Investment?

Retail Investors Are Betting Big on Rocket Lab—Should You Too? — Positive

RKLB   MarketBeat — May 16, 2025

Rocket Lab USA Inc. NASDAQ: RKLB became a retail favorite in 2024, gaining recognition and popularity and surging over 300% in value. While the stock has been relatively flat in 2025, that's the only thing lacking momentum.

image for news Retail Investors Are Betting Big on Rocket Lab—Should You Too?

TakeTwo's Q4 Loss Widens Year Over Year, Revenues Increase — Positive

TTWO   Zacks Investment Research — May 16, 2025

TTWO's fourth-quarter fiscal 2025 revenues rise, benefiting from the successful release of new titles and continued momentum in the existing titles.

image for news TakeTwo's Q4 Loss Widens Year Over Year, Revenues Increase

Byrna Technologies Stock Falls 11% YTD: Is This the Right Time to Buy? — Neutral

BYRN   Zacks Investment Research — May 16, 2025

With BYRN shares recovering, it's time to assess the stock's current standing and determine whether it is an attractive investment opportunity.

image for news Byrna Technologies Stock Falls 11% YTD: Is This the Right Time to Buy?

Primoris Services (PRIM) Is Up 3.20% in One Week: What You Should Know — Positive

PRIM   Zacks Investment Research — May 16, 2025

Does Primoris Services (PRIM) have what it takes to be a top stock pick for momentum investors? Let's find out.

image for news Primoris Services (PRIM) Is Up 3.20% in One Week: What You Should Know

Are You Looking for a Top Momentum Pick? Why Tecnoglass (TGLS) is a Great Choice — Positive

TGLS   Zacks Investment Research — May 16, 2025

Does Tecnoglass (TGLS) have what it takes to be a top stock pick for momentum investors? Let's find out.

image for news Are You Looking for a Top Momentum Pick? Why Tecnoglass (TGLS) is a Great Choice

Red Violet, Inc. (RDVT) Is Up 15.05% in One Week: What You Should Know — Positive

RDVT   Zacks Investment Research — May 16, 2025

Does Red Violet, Inc. (RDVT) have what it takes to be a top stock pick for momentum investors? Let's find out.

image for news Red Violet, Inc. (RDVT) Is Up 15.05% in One Week: What You Should Know

What Makes WidePoint (WYY) a Strong Momentum Stock: Buy Now? — Positive

WYY   Zacks Investment Research — May 16, 2025

Does WidePoint (WYY) have what it takes to be a top stock pick for momentum investors? Let's find out.

image for news What Makes WidePoint (WYY) a Strong Momentum Stock: Buy Now?

Are You Looking for a Top Momentum Pick? Why DBV Technologies S.A. — Positive

DBVT   Zacks Investment Research — May 16, 2025

Does DBV Technologies S.A. (DBVT) have what it takes to be a top stock pick for momentum investors?

image for news Are You Looking for a Top Momentum Pick? Why DBV Technologies S.A.

Backblaze (BLZE) Upgraded to Buy: Here's Why — Positive

BLZE   Zacks Investment Research — May 16, 2025

Backblaze (BLZE) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

image for news Backblaze (BLZE) Upgraded to Buy: Here's Why

Rapt Therapeutics (RAPT) Upgraded to Buy: Here's What You Should Know — Positive

RAPT   Zacks Investment Research — May 16, 2025

Rapt Therapeutics (RAPT) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

image for news Rapt Therapeutics (RAPT) Upgraded to Buy: Here's What You Should Know

Comfort Systems (FIX) Upgraded to Strong Buy: Here's Why — Positive

FIX   Zacks Investment Research — May 16, 2025

Comfort Systems (FIX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

image for news Comfort Systems (FIX) Upgraded to Strong Buy: Here's Why

Verizon announced Friday that it's ending corporate diversity, equity and inclusion (DEI) goals as it faces a Trump administration probe and scrutiny of a proposed acquisition.

image for news Verizon ends DEI programs, diversity goals as it seeks approval for Frontier acquisition